These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 19428249

  • 1. Characterization of lassa virus cell entry inhibitors: determination of the active enantiomer by asymmetric synthesis.
    Whitby LR, Lee AM, Kunz S, Oldstone MB, Boger DL.
    Bioorg Med Chem Lett; 2009 Jul 15; 19(14):3771-4. PubMed ID: 19428249
    [Abstract] [Full Text] [Related]

  • 2. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
    Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, Jia X, Zhang L, Xiao G, Wang W.
    J Virol; 2018 Aug 15; 92(16):. PubMed ID: 29899092
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library.
    Lan X, Zhang Y, Jia X, Dong S, Liu Y, Zhang M, Guo J, Cao J, Guo Y, Xiao G, Wang W.
    Antiviral Res; 2022 Jan 15; 197():105230. PubMed ID: 34965446
    [Abstract] [Full Text] [Related]

  • 10. 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.
    Shrivastava-Ranjan P, Bergeron É, Chakrabarti AK, Albariño CG, Flint M, Nichol ST, Spiropoulou CF.
    mBio; 2016 Dec 20; 7(6):. PubMed ID: 27999160
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G, Trofimenko E, Mayor J, Fedeli C, Moreno H, Michel S, Heulot M, Chevalier N, Zimmer G, Shrestha N, Plattet P, Engler O, Rothenberger S, Widmann C, Kunz S.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30626681
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry.
    Fedeli C, Moreno H, Kunz S.
    Viruses; 2020 Aug 06; 12(8):. PubMed ID: 32781509
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
    Oppliger J, Torriani G, Herrador A, Kunz S.
    J Virol; 2016 Jul 15; 90(14):6412-6429. PubMed ID: 27147735
    [Abstract] [Full Text] [Related]

  • 17. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
    Hulseberg CE, Fénéant L, Szymańska KM, White JM.
    mBio; 2018 Jan 02; 9(1):. PubMed ID: 29295909
    [Abstract] [Full Text] [Related]

  • 18. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR, Guerrero LW, Chakrabarti AK, McMullan LK, Flint M, Bluemling GR, Painter GR, Nichol ST, Spiropoulou CF, Albariño CG.
    Antiviral Res; 2016 Dec 02; 136():9-18. PubMed ID: 27771389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors.
    Otsuka Y, Zhang L, Mou H, Shumate J, Kitzmiller CE, Scampavia L, Bannister TD, Farzan M, Choe H, Spicer TP.
    SLAS Discov; 2024 Sep 02; 29(6):100178. PubMed ID: 39159824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.